Compound 847
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1
- IUPAC name:
4-[3-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid
- InChi:
InChI=1S/C33H35NO4/c1-34(2)21-8-20-33(37,29-11-4-3-5-12-29)30-13-7-14-31(24-30)38-22-19-25-9-6-10-28(23-25)26-15-17-27(18-16-26)32(35)36/h3-7,9-18,23-24,37H,8,19-22H2,1-2H3,(H,35,36)/t33-/m0/s1
- InChiKey:
WFNGHARBPPOEQT-XIFFEERXSA-N
External links
168318056 |
26362175 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 509.26 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.80 | |||
TPSA | 70.00 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5574 | Ansofaxine | DB15052 | |
0.5447 | Tasimelteon | DB09071 | |
0.5421 | Fexofenadine | DB00950 | |
0.5405 | Tramadol | DB00193 | |
0.5319 | Adomeglivant | DB11704 | |
0.5271 | Darifenacin | DB00496 | |
0.5256 | CP-195543 | DB13053 | |
0.5221 | Adapalene | DB00210 | |
0.5191 | Ramelteon | DB00980 | |
0.5182 | Emixustat | DB12608 | |
0.5149 | {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DB07237 | |
0.5077 | Etripamil | DB12605 | |
0.5075 | Meprotixol | DB13822 | |
0.5048 | Terfenadine | DB00342 | |
0.5000 | Fesoterodine | DB06702 |